Actinium Pharmaceuticals, Inc. (ATNM)
NYSEAMERICAN: ATNM · IEX Real-Time Price · USD
6.85
+0.18 (2.70%)
At close: Apr 19, 2024, 4:00 PM
6.89
+0.04 (0.58%)
After-hours: Apr 19, 2024, 5:38 PM EDT

Actinium Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
-48.82-33.02-24.77-22.22-21.9-23.65-26.6-24.32-21.03-24.69
Upgrade
Depreciation & Amortization
0.790.70.520.450.420.050.060.080.050.04
Upgrade
Share-Based Compensation
3.842.81.691.251.31.83.494.37.066.28
Upgrade
Other Operating Activities
-3.1538.171.69-1.1-1.281.231.5-0.84-4.634.02
Upgrade
Operating Cash Flow
-47.348.64-20.87-21.62-21.46-20.57-21.55-20.79-18.54-14.35
Upgrade
Capital Expenditures
-0.15-0.37-0.13-0.25-0.06-0.1-0.02-0.06-0.05-0.15
Upgrade
Other Investing Activities
--------0.05--0.03
Upgrade
Investing Cash Flow
-0.15-0.37-0.13-0.25-0.06-0.1-0.02-0.11-0.05-0.19
Upgrade
Share Issuance / Repurchase
14.8723.1635.3176.6417.4416.9818.8116.0437.8115.87
Upgrade
Debt Issued / Paid
-0-0.05-0.09-0.46-0.3200-0.27-0.28-0.16
Upgrade
Financing Cash Flow
14.8723.1135.2276.1817.1116.9818.8115.7837.5315.71
Upgrade
Net Cash Flow
-32.6231.3914.2254.31-4.41-3.69-2.76-5.1218.941.17
Upgrade
Free Cash Flow
-47.498.28-21-21.87-21.53-20.67-21.58-20.85-18.59-14.5
Upgrade
Free Cash Flow Margin
-58627.16%803.69%-1835.58%-------
Upgrade
Free Cash Flow Per Share
-1.780.34-1.02-1.80-4.33-5.85-9.70-12.91-14.62-15.90
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).